Boothbay Fund Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Boothbay Fund Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-320,000	Closed	-$1.28M	–	1202
2019 Q4	$1.28M	Buy	320,000 +119,242	+59%	+$560K	0.11%	257
2019 Q3	$984K	Buy	+200,758	New	+$1.12M	0.09%	313

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Boothbay Fund Management's DPLO Position: Q1 2020 in Review

Boothbay Fund Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 320,000 shares — an estimated $1.28M sold.

Boothbay Fund Management first reported a position in DPLO in Q3 2019 and held it in 2 quarters. The position peaked at $1.28M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Boothbay Fund Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Boothbay Fund Management sold 320,000 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.28M.
Boothbay Fund Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2019 and held it in 2 quarters.
Boothbay Fund Management's DIPLOMAT PHARMACY, INC. position peaked at $1.28M in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.